Discover the latest articles and insights about Obesity
Weight-loss medications transform lives but aren't a standalone cure New appetite-suppressing drugs like semaglutide and tirzepatide have delivered dramatic results for individuals battling obesi...
Financial sacrifices pay off for self-funded patient Ruth Gonzalez, 56, began taking Eli Lilly's Zepbound last year after her blood pressure spiked, but the $350 monthly cost forced her to cut ba...
Patent expiry sets stage for generic competition India's pharmaceutical market is bracing for a seismic shift as the patent on semaglutide-the active ingredient in Novo Nordisk's blockbuster weig...
Demand for weight-loss treatments rises in Kenya Nairobi's Nairobi Bariatric Center now treats 10 to 15 patients daily, a sharp increase from its early years when clients were rare. The clinic, f...
Rapid weight rebound after discontinuing weight-loss injections Individuals who stop taking GLP-1 weight-loss drugs like Mounjaro or Wegovy regain lost weight at a rate four times faster than tho...
Public perceptions clash with scientific reality on obesity A recent study in The Lancet revealed that 80% of people in the UK, Australia, New Zealand, and the US believe obesity can be entirely...
Weight-loss drugs silence hunger-but at what cost? For millions using GLP-1 medications like Wegovy and Mounjaro, the drugs have muted the persistent mental chatter urging them to eat. Yet stoppi...
WHO urges broader access to obesity drugs as global demand surges The World Health Organization (WHO) has called for expanded and equitable access to GLP-1 obesity medications, warning that fewer...
Off-label use of weight-loss drugs grows among non-obese users A rising number of individuals with no medical need for weight-loss injections are using them intermittently for cosmetic purposes,...
UK expands sugar tax to milkshakes and coffees from 2028 Health Secretary Wes Streeting announced on Tuesday that pre-packaged milkshakes, flavored coffees, and other milk-based drinks high in su...
Thyroid cancer surge puzzles experts as global cases rise faster than other cancers Thyroid cancer incidence has climbed more rapidly in the U.S. and other regions than any other malignancy, defy...
Trump administration negotiates lower prices for obesity medications The Trump administration announced agreements with Eli Lilly and Novo Nordisk on Friday to reduce monthly costs of popular wei...
India's weight-loss drug boom sparks medical and ethical concerns Mumbai diabetologist Rahul Baxi now fields daily inquiries from young professionals seeking prescriptions for weight-loss drugs-o...
Response Time: We aim to respond to all inquiries within 30 days.
Email: support@news.com
Help us improve by reporting any issues with this response.
Thank you for your feedback
